Wegovy (semaglutide) is available in several forms, and the correct instructions depend on the exact prescription you receive. Current U.S. options include single-dose injection pens, prefilled single-dose syringes, a four-dose FlexTouch pen, Wegovy HD 7.2 mg for selected adults, and once-daily tablets.
Which Wegovy presentation do you have?
Single-dose pen
The dose is preset, the needle is concealed, and the injection starts when the pen is pressed firmly against the skin. Wegovy HD 7.2 mg is also supplied as a single-dose pen.
Prefilled syringe
One syringe contains one prescribed dose and has an integrated needle. Use it once, then place the entire syringe into an FDA-cleared sharps container.
Wegovy FlexTouch
One single-patient-use dial pen contains four 2.4 mg doses. Attach a new compatible pen needle for every injection, follow the packaged flow-check instructions, and never share the pen.
Wegovy tablets
Tablets are taken every morning on an empty stomach with no more than four ounces of plain water. The tablet strengths and escalation schedule are different from injection doses.
What is Wegovy approved to treat?
Long-term weight management
Wegovy injection is approved for adults and adolescents age 12 and older with obesity, and for adults with overweight plus at least one weight-related condition. Wegovy tablets are approved for weight management in adults.
Cardiovascular risk reduction
Injection and tablets are approved to reduce cardiovascular death, nonfatal heart attack, or nonfatal stroke in adults with established cardiovascular disease and either obesity or overweight.
Selected adults with MASH
Wegovy injection is approved under accelerated approval for adults with noncirrhotic metabolic dysfunction-associated steatohepatitis and moderate-to-advanced fibrosis (F2–F3). This diagnosis and treatment require specialized evaluation.
Current Wegovy injection dosing schedule
The gradual escalation helps reduce gastrointestinal side effects. If a dose is not tolerated, the FDA labeling allows clinicians to consider delaying the next increase for four weeks.
| When | Weekly dose | What this stage means |
|---|---|---|
| Weeks 1–4 | 0.25 mg | Starting dose used to begin treatment and improve tolerability. |
| Weeks 5–8 | 0.5 mg | First escalation step when the starting dose is tolerated. |
| Weeks 9–12 | 1 mg | Continue only according to the schedule set by your prescriber. |
| Weeks 13–16 | 1.7 mg | Escalation dose and an FDA-labeled maintenance option for several indications. |
| Week 17 onward | 1.7 or 2.4 mg | The recommended maintenance dose depends on the indication, response and tolerability. For most uses, 2.4 mg is recommended. |
| Selected adults only | Up to 7.2 mg | For adult weight reduction only, a clinician may consider Wegovy HD after at least four weeks at 2.4 mg when additional treatment effect is clinically indicated. |
Do not increase your dose on your own. The 7.2 mg dose is not the maintenance dose for cardiovascular-risk reduction, pediatric weight management or MASH.
Current Wegovy tablet dosing schedule
Wegovy tablets are labeled for cardiovascular-risk reduction and weight management in adults. They are not the labeled Wegovy treatment for MASH or pediatric weight management.
| When | Daily dose | How to take it |
|---|---|---|
| Days 1–30 | 1.5 mg | Starting tablet dose. |
| Days 31–60 | 4 mg | First tablet escalation step. |
| Days 61–90 | 9 mg | Second tablet escalation step. |
| Day 91 onward | 25 mg | Recommended adult maintenance tablet dose. |
- Take one tablet in the morning on an empty stomach with up to four ounces of plain water.
- Do not use another beverage. Swallow the tablet whole; do not split, crush, chew or dissolve it.
- Wait at least 30 minutes before food, beverages or other oral medicines.
- If you miss a tablet, skip it and take the next dose the following day. Do not double the dose.
Weekly injection timing and missed doses
Choose one weekly day
Inject once weekly, at any time of day, with or without meals. You may change the weekly day if your last injection was at least 48 hours earlier.
Next dose is more than 48 hours away
Take the missed injection as soon as possible, then resume your regular weekly schedule.
Next dose is less than 48 hours away
Skip the missed injection and take the next dose on the regularly scheduled day. If two or more consecutive weekly doses are missed, contact your prescriber because re-escalation at a lower dose may be needed.
How to use the Wegovy single-dose pen
These reminders supplement—but do not replace—the Instructions for Use in the carton. The same basic activation method applies to the current preset single-dose pens, including Wegovy HD.
- Inspect the pen. Confirm the medicine, dose and expiration date. The solution should be clear and colorless with no particles. Do not use a damaged, dropped, frozen or previously used pen.
- Choose and clean the site. Use the abdomen, thigh or upper arm. Rotate the exact spot each week and avoid tender, bruised, hard, scarred or damaged skin.
- Remove the cap only when ready. Pull it straight off. Do not touch or press the needle cover.
- Press firmly against the skin. The injection begins when the needle cover is pressed firmly into the skin. There is no separate injection button on the single-dose pen.
- Keep steady pressure. You will hear two clicks. Continue pressing until the yellow bar stops moving; the injection generally takes about 5–10 seconds.
- Dispose safely. Lift the pen slowly, then place the entire used pen directly into an FDA-cleared sharps container. Do not reuse or recycle it.
Prefilled syringe and FlexTouch reminders
Prefilled single-dose syringe
- Keep the needle cap on until you are ready.
- Confirm the prescribed strength and inspect the solution.
- Inject only after you have received presentation-specific training.
- Use once and place the entire syringe into a sharps container.
Four-dose FlexTouch pen
- One pen contains four weekly 2.4 mg doses for one patient.
- Attach a new compatible pen needle for each injection and complete the packaged flow-check steps.
- Dial only the labeled 2.4 mg dose; do not count clicks.
- Remove and discard the needle after every dose, then store the pen without a needle attached.
How to store Wegovy
| Presentation | Usual storage | Important limits |
|---|---|---|
| Single-dose pen or syringe | Refrigerate at 36°F–46°F (2°C–8°C) in the original carton. | Before cap removal, it may be kept at 46°F–86°F (8°C–30°C) for up to 28 days. Protect from light and discard after use. |
| FlexTouch four-dose pen | Refrigerate before first use at 36°F–46°F (2°C–8°C). | After first use, refrigerate or store at 59°F–86°F (15°C–30°C) for up to 56 days. Keep capped, protect from heat and light, and store without a needle attached. |
| Tablets | Store at room temperature, normally 68°F–77°F (20°C–25°C). | Keep tablets in the original closed bottle in a dry place and protect them from moisture. |
Never freeze Wegovy or use an injection that has been frozen. Do not use a pen or syringe exposed to temperatures above 86°F or outside its labeled storage window.
Common side effects and when to call
Common effects include nausea, diarrhea, vomiting, constipation, abdominal pain, headache, fatigue, indigestion, dizziness, abdominal bloating, burping, gas, reflux and injection-site reactions. Hydration and gradual dose escalation can matter, but persistent or severe symptoms require medical advice.
Seek urgent care for swelling of the face, lips, tongue or throat; trouble breathing or swallowing; fainting; or other signs of a serious allergic reaction. Severe, persistent abdominal pain—especially if it reaches the back—may signal pancreatitis and requires prompt evaluation.
Contact your clinician for symptoms of gallbladder disease; vomiting or diarrhea that makes hydration difficult; major vision changes if you have diabetes; repeated low blood sugar when using insulin or a medicine that increases insulin release; a racing heartbeat; or a neck lump, persistent hoarseness, trouble swallowing or shortness of breath.
Who should not use Wegovy?
- Do not use Wegovy with another semaglutide-containing product or another GLP-1 receptor agonist.
- Wegovy is contraindicated with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
- Do not use it after a serious allergic reaction to semaglutide or another Wegovy ingredient.
- Wegovy is not recommended for severe gastroparesis. Tell your clinician about significant delayed stomach emptying or severe gastrointestinal disease.
Pregnancy, procedures and other medicines
- Pregnancy: for weight reduction or cardiovascular-risk reduction, stop Wegovy and contact your prescriber when pregnancy is recognized. Because semaglutide remains in the body for weeks, the label advises stopping at least two months before a planned pregnancy. MASH treatment during pregnancy requires a specific risk-benefit decision.
- Procedures and anesthesia: Wegovy delays stomach emptying and may affect aspiration risk. Tell the surgeon, proceduralist and anesthesia team that you use semaglutide; follow their individualized medication and fasting instructions.
- Diabetes medicines: insulin or medicines that increase insulin release can increase the risk of low blood sugar. Glucose monitoring and medication adjustments may be needed.
- Oral medicines: delayed stomach emptying can affect absorption. Tell your clinician about medicines that require precise blood levels or close monitoring.
Coverage, cost and JourneyLite care
Wegovy coverage varies by insurance plan and employer. Manufacturer programs, cash pricing, covered presentations and pharmacy availability can change, so fixed dollar estimates become outdated quickly. JourneyLite can review medical eligibility, discuss coverage and self-pay considerations, and build a plan that includes nutrition guidance and follow-up rather than providing a prescription without ongoing care.
Frequently Asked Questions
Is Wegovy the same as Ozempic?
What dose does Wegovy injection usually start with?
Do I have to increase my Wegovy dose every month?
What is Wegovy HD 7.2 mg?
Does Wegovy now come as a tablet?
What should I do if I miss a Wegovy injection?
Can I change my weekly Wegovy injection day?
How long can a single-dose Wegovy pen stay out of the refrigerator?
How long is the Wegovy FlexTouch pen usable after first use?
Can I take Wegovy before surgery or a procedure?
Does insurance cover Wegovy?
How long do people stay on Wegovy?
Need help deciding whether Wegovy fits your plan?
JourneyLite provides physician-led medical weight management across Ohio, Kentucky and Indiana, including medication selection, dose management, nutrition support and long-term follow-up.
Medical review and references
Reviewed by Trace Curry, MD, FASMBS
Clinical review date: August 15, 2026
- FDA: Current Wegovy Prescribing Information and Instructions for Use
- FDA: Cardiovascular-risk-reduction indication
- FDA: MASH indication
- FDA: Safe sharps disposal
This page is educational and does not replace the Medication Guide, presentation-specific Instructions for Use or individualized medical advice.
